Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Accepts healthy volunteers

A Prospective Observational Study of the Breath Responsive Variable Bolus Oxygen Conserving Device

ClinicalTrials.gov ID: NCT02627599

Public ClinicalTrials.gov record NCT02627599. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 3:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Evaluate Improvement in the Quality of Life and Health and Economic Outcomes of Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

* Evaluate subjects in an prospective observational study * Subjects will be administered scientifically validated questionnaires * Evaluate Quality Improvement and Oxygen Utilization Improvements. 1\. Functional capability, dyspnea, oxygen saturation as primary endpoints 1. Baseline Dyspnea Index (BDI) 2. Transitional Dyspnea Index (TDI) 3. Chronic Respiratory Disease Questionnaire (CRQ) 4. Six minute walk distance (6MWD) 5. Oxygen saturation using pulse oximeter * The secondary endpoints: 1. Portable oxygen source utilization 2. Health care utilization (emergency room encounters, hospital admissions)

Study identification

NCT ID
NCT02627599
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
StratiHealth
Industry
Enrollment
35 participants

Conditions and interventions

Eligibility (public fields only)

Age range
65 Years to 85 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2015
Primary completion
Oct 31, 2016
Completion
Oct 31, 2016
Last update posted
Aug 14, 2018

2015 – 2016

United States locations

U.S. sites
3
U.S. states
1
U.S. cities
3
Facility City State ZIP Site status
KP Oceanside Medical Office Building Oceanside California 92054
Tcmc - Mob Vista California 92054
Pathway Medical Group Westminster California 92683

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02627599, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 14, 2018 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02627599 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →